ESR1 and breast cancer: Li and colleagues showed that eAGR2 formed intermediate interaction with ER-α to induce the expression of insulin-like growth factor-1 receptor (IGF-1), which resulted in enhanced proliferation, migration and EMT process in breast cancer cells [31].